Iperion Limited/Announcement
Iperion Limited logo

D&O Ongoing Disclosure – Joseph van Wijk

Insider Disclosure14 November 2017IPRReal Estate

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and

Name of listed issuer:

Lateral Corporation Limited

Date this disclosure made:

14/11/2017

Date of last disclosure:

13/09/2017

Director or senior manager giving disclosure

Full name(s):

Joseph van Wijk

Name of listed issuer:

Lateral Corporation Limited

Name of related body corporate (if applicable):

N/A

Position held in listed issuer:

Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:

Ordinary Shares

Nature of the affected relevant interest(s):

Legal and beneficial interest

For that relevant interest-

Number held in class before acquisition or disposal:

16,395,630 (includes 7,960,501 non

voting shares)

Number held in class after acquisition or disposal:

12,395,630 (all voting shares)

Current registered holder(s):

Joseph van Wijk; Matthew van Wijk; Mary

Michelle van Wijk; Elizabeth Mary van

Wijk; Anna Mary van Wijk; Trinity Portfolio

Limited

Registered holder(s) once transfers are registered:

Trinity Portfolio Limited; Lei Pei

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates:

6

Details of transactions requiring disclosure-

Date of transaction:

7/11/2017 and 14/11/2017

Nature of transaction:

1. Consolidation by way of off-market

transfer of a total of 81,050 ordinary

shares from various family holdings

(Joseph van Wijk 77,250 shares,

Mathhew van Wijk 800 shares, Mary

Michelle van Wijk 1,000 shares, Elizabeth

Mary van Wijk 1,000 shares, Anna Mary

van Wijk 1,000 shares) to Trinity Portfolio

Limited. 2. The sale by way of off-market

transfer of 4,000,000 ordinary shares from

Trinity Portfolio to Lei Pei. 3. Conversion

of 7,960,501 non voting shares held by

Trinity Portfolios to voting shares in

accordance with the terms of the share

issue approved by shareholders at a

special meeting of shareholders held on 7

August 2017.

Name of any other party or parties to the transaction (if known):
See above.

The consideration, expressed in New Zealand dollars, paid or received for the acquisition

or disposal. If the consideration was not in cash and cannot be readily by converted into a

cash value, describe the consideration:

1.Total acquistions: $542.19. 2.Disposal:

$26,758.45.

3.Conversion: $0.

Number of financial products to which the transaction related:

1.Acquistions: 81,050.

2.Disposal: 4,000,000.

3.Conversion: 7,960,501.

If the issuer has a financial products trading policy that prohibits directors or senior

managers from trading during any period without written clearance (a closed period)

include the following details—

Whether relevant interests were acquired or disposed of during a closed period:

N/A

Whether prior written clearance was provided to allow the acquisition or disposal to

proceed during the closed period:

N/A

Date of the prior written clearance (if any):

N/A

Summary of other relevant interests after acquisition or disposal:

Class of quoted financial products:

N/A

Nature of relevant interest:

N/A

For that relevant interest,-

Number held in class:

N/A

Current registered holder(s):

N/A

Certification

I certify that, to the best of my knowledge and belief, the information contained in this

disclosure is correct and that I am duly authorised to make this disclosure by all persons

for whom it is made.

Signature of director or officer:

Date of signature:

or

Signature of person authorised to sign on behalf of director or officer:

Date of signature:

14/11/2017

Name and title of authorised person:Matt Yates, Solicitor

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • PEB — Pacific Edge Limited: D&O Ongoing Disclosures – Multiple
    2017-11-14

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Pacific Edge Limited Date this disclosure made: 15-Nov-17 Date of last disclosure:…”

  • FPH — Fisher & Paykel Healthcare Corporation Limited: D&O Ongoing Disclosures – Multiple
    2017-12-21

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 21 Decem…”

  • NZX — NZX Limited: D&O Ongoing Disclosure – Jon Macdonald
    2017-12-21

    Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: NZX Limited Date this disclosure made: 22-Dec-17 Date of last disclosure: 4-Sep-1…”